| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.6 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.23 | 0.6 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |